Metagenomic Sequencing
Metagenomics is the study of genetic material recovered directly from environmental samples. The ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Technology: 2016 VS 2021 VS 2027 1.2.2 Separation Techniques 1.2.3 Detection Techniques 1.2.4 Others 1.3 Market by Application 1.3.1 Global Metabolic Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Drug Discovery 1.3.3 Nutrigenomics 1.3.4 Toxicology Testing 1.3.5 Personalized Medicine 1.3.6 Functional Genomics 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Metabolic Biomarker Testing Market Perspective (2016-2027) 2.2 Metabolic Biomarker Testing Growth Trends by Regions 2.2.1 Metabolic Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Metabolic Biomarker Testing Historic Market Share by Regions (2016-2021) 2.2.3 Metabolic Biomarker Testing Forecasted Market Size by Regions (2022-2027) 2.3 Metabolic Biomarker Testing Industry Dynamic 2.3.1 Metabolic Biomarker Testing Market Trends 2.3.2 Metabolic Biomarker Testing Market Drivers 2.3.3 Metabolic Biomarker Testing Market Challenges 2.3.4 Metabolic Biomarker Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Metabolic Biomarker Testing Players by Revenue 3.1.1 Global Top Metabolic Biomarker Testing Players by Revenue (2016-2021) 3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Players (2016-2021) 3.2 Global Metabolic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Metabolic Biomarker Testing Revenue 3.4 Global Metabolic Biomarker Testing Market Concentration Ratio 3.4.1 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Metabolic Biomarker Testing Revenue in 2020 3.5 Metabolic Biomarker Testing Key Players Head office and Area Served 3.6 Key Players Metabolic Biomarker Testing Product Solution and Service 3.7 Date of Enter into Metabolic Biomarker Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Metabolic Biomarker Testing Breakdown Data by Technology 4.1 Global Metabolic Biomarker Testing Historic Market Size by Technology (2016-2021) 4.2 Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2022-2027) 5 Metabolic Biomarker Testing Breakdown Data by Application 5.1 Global Metabolic Biomarker Testing Historic Market Size by Application (2016-2021) 5.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Metabolic Biomarker Testing Market Size (2016-2027) 6.2 North America Metabolic Biomarker Testing Market Size by Technology 6.2.1 North America Metabolic Biomarker Testing Market Size by Technology (2016-2021) 6.2.2 North America Metabolic Biomarker Testing Market Size by Technology (2022-2027) 6.2.3 North America Metabolic Biomarker Testing Market Size by Technology (2016-2027) 6.3 North America Metabolic Biomarker Testing Market Size by Application 6.3.1 North America Metabolic Biomarker Testing Market Size by Application (2016-2021) 6.3.2 North America Metabolic Biomarker Testing Market Size by Application (2022-2027) 6.3.3 North America Metabolic Biomarker Testing Market Size by Application (2016-2027) 6.4 North America Metabolic Biomarker Testing Market Size by Country 6.4.1 North America Metabolic Biomarker Testing Market Size by Country (2016-2021) 6.4.2 North America Metabolic Biomarker Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Metabolic Biomarker Testing Market Size (2016-2027) 7.2 Europe Metabolic Biomarker Testing Market Size by Technology 7.2.1 Europe Metabolic Biomarker Testing Market Size by Technology (2016-2021) 7.2.2 Europe Metabolic Biomarker Testing Market Size by Technology (2022-2027) 7.2.3 Europe Metabolic Biomarker Testing Market Size by Technology (2016-2027) 7.3 Europe Metabolic Biomarker Testing Market Size by Application 7.3.1 Europe Metabolic Biomarker Testing Market Size by Application (2016-2021) 7.3.2 Europe Metabolic Biomarker Testing Market Size by Application (2022-2027) 7.3.3 Europe Metabolic Biomarker Testing Market Size by Application (2016-2027) 7.4 Europe Metabolic Biomarker Testing Market Size by Country 7.4.1 Europe Metabolic Biomarker Testing Market Size by Country (2016-2021) 7.4.2 Europe Metabolic Biomarker Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Metabolic Biomarker Testing Market Size (2016-2027) 8.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Technology 8.2.1 Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2016-2021) 8.2.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2022-2027) 8.2.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2016-2027) 8.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Application 8.3.1 Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific Metabolic Biomarker Testing Market Size by Region 8.4.1 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Metabolic Biomarker Testing Market Size (2016-2027) 9.2 Latin America Metabolic Biomarker Testing Market Size by Technology 9.2.1 Latin America Metabolic Biomarker Testing Market Size by Technology (2016-2021) 9.2.2 Latin America Metabolic Biomarker Testing Market Size by Technology (2022-2027) 9.2.3 Latin America Metabolic Biomarker Testing Market Size by Technology (2016-2027) 9.3 Latin America Metabolic Biomarker Testing Market Size by Application 9.3.1 Latin America Metabolic Biomarker Testing Market Size by Application (2016-2021) 9.3.2 Latin America Metabolic Biomarker Testing Market Size by Application (2022-2027) 9.3.3 Latin America Metabolic Biomarker Testing Market Size by Application (2016-2027) 9.4 Latin America Metabolic Biomarker Testing Market Size by Country 9.4.1 Latin America Metabolic Biomarker Testing Market Size by Country (2016-2021) 9.4.2 Latin America Metabolic Biomarker Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Metabolic Biomarker Testing Market Size (2016-2027) 10.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Technology 10.2.1 Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2016-2021) 10.2.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2022-2027) 10.2.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2016-2027) 10.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Application 10.3.1 Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa Metabolic Biomarker Testing Market Size by Country 10.4.1 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Agilent Technologies 11.1.1 Agilent Technologies Company Details 11.1.2 Agilent Technologies Business Overview 11.1.3 Agilent Technologies Metabolic Biomarker Testing Introduction 11.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2016-2021) 11.1.5 Agilent Technologies Recent Development 11.2 Bio-Rad Laboratories 11.2.1 Bio-Rad Laboratories Company Details 11.2.2 Bio-Rad Laboratories Business Overview 11.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Introduction 11.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2016-2021) 11.2.5 Bio-Rad Laboratories Recent Development 11.3 Bruker 11.3.1 Bruker Company Details 11.3.2 Bruker Business Overview 11.3.3 Bruker Metabolic Biomarker Testing Introduction 11.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2016-2021) 11.3.5 Bruker Recent Development 11.4 Danaher 11.4.1 Danaher Company Details 11.4.2 Danaher Business Overview 11.4.3 Danaher Metabolic Biomarker Testing Introduction 11.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2016-2021) 11.4.5 Danaher Recent Development 11.5 Waters Corporation 11.5.1 Waters Corporation Company Details 11.5.2 Waters Corporation Business Overview 11.5.3 Waters Corporation Metabolic Biomarker Testing Introduction 11.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2016-2021) 11.5.5 Waters Corporation Recent Development 11.6 Thermo Fisher Scientific 11.6.1 Thermo Fisher Scientific Company Details 11.6.2 Thermo Fisher Scientific Business Overview 11.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Introduction 11.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2016-2021) 11.6.5 Thermo Fisher Scientific Recent Development 11.7 Biocrates Life Sciences 11.7.1 Biocrates Life Sciences Company Details 11.7.2 Biocrates Life Sciences Business Overview 11.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Introduction 11.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2016-2021) 11.7.5 Biocrates Life Sciences Recent Development 11.8 Human Metabolome Technologies 11.8.1 Human Metabolome Technologies Company Details 11.8.2 Human Metabolome Technologies Business Overview 11.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Introduction 11.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2016-2021) 11.8.5 Human Metabolome Technologies Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Metabolic Biomarker Testing Market Size Growth Rate by Technology (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Separation Techniques Table 3. Key Players of Detection Techniques Table 4. Key Players of Others Table 5. Global Metabolic Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Metabolic Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Metabolic Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Metabolic Biomarker Testing Market Share by Regions (2016-2021) Table 9. Global Metabolic Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Metabolic Biomarker Testing Market Share by Regions (2022-2027) Table 11. Metabolic Biomarker Testing Market Trends Table 12. Metabolic Biomarker Testing Market Drivers Table 13. Metabolic Biomarker Testing Market Challenges Table 14. Metabolic Biomarker Testing Market Restraints Table 15. Global Metabolic Biomarker Testing Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Metabolic Biomarker Testing Market Share by Players (2016-2021) Table 17. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Biomarker Testing as of 2020) Table 18. Ranking of Global Top Metabolic Biomarker Testing Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Metabolic Biomarker Testing Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Metabolic Biomarker Testing Product Solution and Service Table 22. Date of Enter into Metabolic Biomarker Testing Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million) Table 25. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2016-2021) Table 26. Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2022-2027) (US$ Million) Table 27. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2022-2027) & (US$ Million) Table 28. Global Metabolic Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Metabolic Biomarker Testing Revenue Market Share by Application (2016-2021) Table 30. Global Metabolic Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Metabolic Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million) Table 33. North America Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million) Table 34. North America Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 35. North America Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Metabolic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Metabolic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million) Table 39. Europe Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million) Table 40. Europe Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Metabolic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Metabolic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million) Table 45. Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million) Table 46. Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million) Table 51. Latin America Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million) Table 52. Latin America Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Metabolic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Metabolic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million) Table 57. Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million) Table 58. Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 62. Agilent Technologies Company Details Table 63. Agilent Technologies Business Overview Table 64. Agilent Technologies Metabolic Biomarker Testing Product Table 65. Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million) Table 66. Agilent Technologies Recent Development Table 67. Bio-Rad Laboratories Company Details Table 68. Bio-Rad Laboratories Business Overview Table 69. Bio-Rad Laboratories Metabolic Biomarker Testing Product Table 70. Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million) Table 71. Bio-Rad Laboratories Recent Development Table 72. Bruker Company Details Table 73. Bruker Business Overview Table 74. Bruker Metabolic Biomarker Testing Product Table 75. Bruker Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million) Table 76. Bruker Recent Development Table 77. Danaher Company Details Table 78. Danaher Business Overview Table 79. Danaher Metabolic Biomarker Testing Product Table 80. Danaher Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million) Table 81. Danaher Recent Development Table 82. Waters Corporation Company Details Table 83. Waters Corporation Business Overview Table 84. Waters Corporation Metabolic Biomarker Testing Product Table 85. Waters Corporation Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million) Table 86. Waters Corporation Recent Development Table 87. Thermo Fisher Scientific Company Details Table 88. Thermo Fisher Scientific Business Overview Table 89. Thermo Fisher Scientific Metabolic Biomarker Testing Product Table 90. Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million) Table 91. Thermo Fisher Scientific Recent Development Table 92. Biocrates Life Sciences Company Details Table 93. Biocrates Life Sciences Business Overview Table 94. Biocrates Life Sciences Metabolic Biomarker Testing Product Table 95. Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million) Table 96. Biocrates Life Sciences Recent Development Table 97. Human Metabolome Technologies Company Details Table 98. Human Metabolome Technologies Business Overview Table 99. Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million) Table 100. Human Metabolome Technologies Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Metabolic Biomarker Testing Market Share by Technology: 2020 VS 2027 Figure 2. Separation Techniques Features Figure 3. Detection Techniques Features Figure 4. Others Features Figure 5. Global Metabolic Biomarker Testing Market Share by Application: 2020 VS 2027 Figure 6. Drug Discovery Case Studies Figure 7. Nutrigenomics Case Studies Figure 8. Toxicology Testing Case Studies Figure 9. Personalized Medicine Case Studies Figure 10. Functional Genomics Case Studies Figure 11. Others Case Studies Figure 12. Metabolic Biomarker Testing Report Years Considered Figure 13. Global Metabolic Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Metabolic Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Metabolic Biomarker Testing Market Share by Regions: 2020 VS 2027 Figure 16. Global Metabolic Biomarker Testing Market Share by Regions (2022-2027) Figure 17. Global Metabolic Biomarker Testing Market Share by Players in 2020 Figure 18. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Biomarker Testing as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Metabolic Biomarker Testing Revenue in 2020 Figure 20. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2016-2021) Figure 21. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2022-2027) Figure 22. North America Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Metabolic Biomarker Testing Market Share by Technology (2016-2027) Figure 24. North America Metabolic Biomarker Testing Market Share by Application (2016-2027) Figure 25. North America Metabolic Biomarker Testing Market Share by Country (2016-2027) Figure 26. United States Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Metabolic Biomarker Testing Market Share by Technology (2016-2027) Figure 30. Europe Metabolic Biomarker Testing Market Share by Application (2016-2027) Figure 31. Europe Metabolic Biomarker Testing Market Share by Country (2016-2027) Figure 32. Germany Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Metabolic Biomarker Testing Market Share by Technology (2016-2027) Figure 40. Asia-Pacific Metabolic Biomarker Testing Market Share by Application (2016-2027) Figure 41. Asia-Pacific Metabolic Biomarker Testing Market Share by Region (2016-2027) Figure 42. China Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Metabolic Biomarker Testing Market Share by Technology (2016-2027) Figure 50. Latin America Metabolic Biomarker Testing Market Share by Application (2016-2027) Figure 51. Latin America Metabolic Biomarker Testing Market Share by Country (2016-2027) Figure 52. Mexico Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Metabolic Biomarker Testing Market Share by Technology (2016-2027) Figure 56. Middle East & Africa Metabolic Biomarker Testing Market Share by Application (2016-2027) Figure 57. Middle East & Africa Metabolic Biomarker Testing Market Share by Country (2016-2027) Figure 58. Turkey Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Agilent Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021) Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021) Figure 63. Bruker Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021) Figure 64. Danaher Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021) Figure 65. Waters Corporation Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021) Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021) Figure 67. Biocrates Life Sciences Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021) Figure 68. Human Metabolome Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed
Agilent Technologies Bio-Rad Laboratories Bruker Danaher Waters Corporation Thermo Fisher Scientific Biocrates Life Sciences Human Metabolome Technologies
Metagenomics is the study of genetic material recovered directly from environmental samples. The ... Read More
A spine tumor is an abnormal growth of tissue found in and/or around the spinal column and/or spi ... Read More
mHealth is an abbreviation for mobile health, a term used for the practice of medicine and public ... Read More
A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate (usually a glass ... Read More